Two-year treatment outcomes of patients enrolled in India’s national first-line antiretroviral therapy programme.

Bachani, Damodar; Garg, Renu; Rewari, Bharat B; Hegg, Lea; Rajasekaran, Sikhamani; Deshpande, Alaka; Emmanuel, K V; Chan, Polin; Rao, K Sujatha.
Artículo en Inglés | IMSEAR | ID: sea-139094

Documentos relacionados

  1. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review.
  2. Achieving UNAIDS Viral Suppression Goal: Experience from a Tertiary Care Public Hospital, Western India.
  3. Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV.
  4. Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design.
  5. Strategies for an HIV cure: progress and challenges.
  6. Preparation of a Key Intermediate En Route to the Anti-HIV Drug Lenacapavir.
  7. Human immunodeficiency virus infection challenges: Current therapeutic limitations and strategies for improved management through long-acting injectable formulation.
  8. Low-level viral loads and virological failure in the integrase strand transfer era.
  9. No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY Study.
  10. Durability of single tablet regimen for patients with HIV infection in Southern Taiwan: data from a real-world setting.